Amycretin, a dual GLP-1/amylin agonist, has entered Phase 3 trials and may offer improved efficacy over current options
MPNs and MDS are chronic blood cancers caused by abnormal stem cells in the bone marrow
Patients should be counseled that side effects are generally dose-dependent and transient
Drug details Vyvanse comes in the following forms that are taken by mouth: chewable tablet, which is available in strengths of 10 milligrams (mg), 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg capsule, which is available in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg Vyvanse is taken once per day
doi: 10.1016/S0021-9258(19)36565-2 8 LauJBlochPSchafferLPetterssonISpetzlerJKofoedJet al
An ongoing study is currently collecting information about the use and safety of semaglutide during pregnancy